Search

Your search keyword '"Santosha"' showing total 53 results

Search Constraints

Start Over You searched for: Author "Santosha" Remove constraint Author: "Santosha" Database ScienceDirect Remove constraint Database: ScienceDirect
53 results on '"Santosha"'

Search Results

10. Retrospective characterization of nodal marginal zone lymphoma

11. TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy

15. Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses

16. Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease

31. Characterization of a Large Cohort of Patients with Nodal Marginal Zone Lymphoma Shows Prolonged Survival, Time-to-Treatment, and Time-to-Transformation

32. Immune Signature of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

33. Molecular Profiling across Lymphoma Subtypes Using MSK-Impact Next Generation Sequencing

35. Mo1246 DIFFERENCES IN GENETIC ANCESTRY AND PRESENCE OF GASTRIC PRECURSOR LESIONS IN INDIVIDUALS WITH EARLY AND AVERAGE ONSET GASTRIC CANCER

39. Favorable Outcomes Among Patients with T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Treated with Higher-Intensity Therapy in the Rituximab Era

44. Contributors

47. Phase II Study of Pembrolizumab Plus GVD As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

48. Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

49. High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed and Refractory Classical Hodgkin Lymphoma

50. List of contributors

Catalog

Books, media, physical & digital resources